Carbocysteine Overview Categories 25 Drugs acting on the respiratory tract25.2 Antitussives25.2.2 Expectorants Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Carbocysteine Manufacturers of Carbocysteine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Carbocysteine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 750 to 750 mg750 (750)8 hourlyPOInitially (or 2.25gm in daily divided doses.)250 to 250 mg250 (250)8 hourlyPO(Maintenance dose) when a responce is obtained. (or 1.5gm in daily divided doses as condition improves) Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Carbocysteine is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Carbocysteine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Carbocysteine Back to top Manufacturers of Carbocysteine in Pakistan Aventis Kaizen Back to top Previous Drug Generic - Next Drug Generic
Carbocysteine Overview Categories 25 Drugs acting on the respiratory tract25.2 Antitussives25.2.2 Expectorants Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Carbocysteine Manufacturers of Carbocysteine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Carbocysteine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 750 to 750 mg750 (750)8 hourlyPOInitially (or 2.25gm in daily divided doses.)250 to 250 mg250 (250)8 hourlyPO(Maintenance dose) when a responce is obtained. (or 1.5gm in daily divided doses as condition improves) Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Carbocysteine is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Carbocysteine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Carbocysteine Back to top Manufacturers of Carbocysteine in Pakistan Aventis Kaizen Back to top Previous Drug Generic - Next Drug Generic